NR3C2 and primary aldosteronism: Interruption of MR-mediated mechanisms might explain why, in the long term, treatment of primary aldosteronism with MR antagonists has comparable effects to the removal of APA in reducing left ventricular mass although this response occurs later than removal of excess circulating aldosterone by adrenalectomy.